By John K. Waters
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Irish startup CergenX's advanced AI-powered "Wave" device for neonatal brain monitoring. The company has also been accepted into the FDA's Total Product Lifecycle Advisory Program (TAP), positioning the Wave device for accelerated development and regulatory review.
Read Now
By John K. Waters
Haptikos, a startup specializing in lifelike touch-based spatial technology, introduces its flagship hand exoskeleton, bringing realism to virtual interactions with haptic responses from extended reality devices.
Read Now
By John K. Waters
Percipio Health, a Plano, Texas-based startup specializing in population health monitoring, has officially launched with a new platform that promises to lower costs and improve care outcomes using artificial intelligence and smartphone-based technology.
Read Now
By John K. Waters
Health-care technology company Waystar announced on Monday the launch of a new generative AI solution aimed at addressing the growing financial and administrative burden of health insurance claim denials.
Read Now
By John K. Waters
GE HealthCare has signed a landmark seven-year agreement with Sutter Health, a nonprofit healthcare provider based in Sacramento, California, to deliver cutting-edge AI-powered medical imaging technology and digital solutions across its network.
Read Now
By John K. Waters
Nvidia announced a series of groundbreaking collaborations at the J.P. Morgan Healthcare Conference in San Francisco on Monday. These partnerships, spanning healthcare, life sciences, and biopharma, aim to accelerate the adoption and scalability of AI models across the sector, driving advancements in diagnostics, drug discovery, and precision medicine.
Read Now
By John K. Waters
The U.S. Department of Health and Human Services (HHS) has unveiled its groundbreaking Artificial Intelligence Strategic Plan, a nearly 200-page framework designed to transform healthcare and human services through safe, ethical, and innovative applications of artificial intelligence.
Read Now
By John K. Waters
ZEISS Medical Technology announced that its MEL 90 excimer laser has received approval from the U.S. Food and Drug Administration (FDA), granting it simultaneous approval for treating myopia, hyperopia, and mixed astigmatism. The FDA clearance positions the device as a versatile addition to the U.S. refractive surgery market, aiming to enhance patient outcomes and surgical efficiency.
Read Now
By
From AI-powered mirrors to needle-free injections, the annual Consumer Electronics Show (CES), which drew thousands of attendees to Las Vegas last week, featured another crop of groundbreaking innovations.
Read Now
By John K. Waters
Genomic sequencing company Illumina, announces a strategic collaboration with chipmaker NVIDIA to leverage artificial intelligence (AI) in accelerating the analysis of "multiomic" data, which the two companies say will revolutionize clinical research, genomics AI development, and drug discovery.
Read Now